News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Soteropoulos Paula
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/19/2023 |
4
| Soteropoulos Paula (Director) has filed a Form 4 on Rallybio Corp|
Txns:
| Granted 15,490 options to buy
@ $5.64, valued at
$87.4k
|
|
| 03/01/2023 |
4
| Soteropoulos Paula (Director) has filed a Form 4 on uniQure N.V.|
Txns:
| Sold 384 shares
@ $19.97, valued at
$7.7k
|
|
| 01/20/2023 |
4
| Soteropoulos Paula (Director) has filed a Form 4 on uniQure N.V.|
Txns:
| Sold 6,000 shares
@ $22.59, valued at
$135.5k
Exercised 6,000 options to buy
@ $5.37, valued at
$32.2k
|
|
| 12/15/2022 |
4
| Soteropoulos Paula (Director) has filed a Form 4 on uniQure N.V.|
Txns:
| Sold 3,000 shares
@ $23.45, valued at
$70.4k
Sold 3,800 shares
@ $23.43, valued at
$89k
Exercised 3,000 options to buy
@ $5.37, valued at
$16.1k
Exercised 3,800 options to buy
@ $0 |
|
| 12/01/2022 |
4
| Soteropoulos Paula (Director) has filed a Form 4 on uniQure N.V.|
Txns:
| Sold 6,200 shares
@ $25.38, valued at
$157.4k
Exercised 6,200 options to buy
@ $0 |
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Soteropoulos Paula (Director) has filed a Form 4 on Rallybio Corp|
Txns:
| Granted 5,369 options to buy
@ $10.38, valued at
$55.7k
|
|
| 07/29/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2020 |
4
| Soteropoulos Paula (Director) has filed a Form 4 on uniQure N.V.|
Txns:
| Sold 1,300 shares
@ $60.58, valued at
$78.8k
Sold 822 shares
@ $61.53, valued at
$50.6k
|
|
| 01/30/2020 |
4
| Soteropoulos Paula (Director) has filed a Form 4 on uniQure N.V.|
Txns:
| Sold 807 shares
@ $62.19, valued at
$50.2k
|
|
| 01/08/2020 |
4
| Soteropoulos Paula (Director) has filed a Form 4 on uniQure N.V.|
Txns:
| Sold 3,000 shares
@ $72.18, valued at
$216.5k
|
|
| 12/17/2019 |
4
| Soteropoulos Paula (Director) has filed a Form 4 on uniQure N.V.|
Txns:
| Sold 2,000 shares
@ $70.5, valued at
$141k
Exercised 2,000 options to buy
@ $5.37, valued at
$10.7k
|
|
| 12/09/2019 |
4
| Soteropoulos Paula (Director) has filed a Form 4 on uniQure N.V.|
Txns:
| Sold 1,700 shares
@ $63.69, valued at
$108.3k
Sold 7,382 shares
@ $64.39, valued at
$475.3k
Sold 2,500 shares
@ $67.5, valued at
$168.8k
|
|
| 09/30/2019 |
4
| Soteropoulos Paula (CEO) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 1,113,492 shares
@ $16.64, valued at
$18.5M
Paid exercise price by delivering 95,156 shares
@ $16.64, valued at
$1.6M
Paid exercise price by delivering 175,064 shares
@ $16.64, valued at
$2.9M
Exercised 1,711,079 options to buy
@ $6.48, valued at
$11.1M
Exercised 145,303 options to buy
@ $6.48, valued at
$941.6k
Exercised 205,479 options to buy
@ $12.21, valued at
$2.5M
|
|
| 04/09/2019 |
4
| Soteropoulos Paula (CEO) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Sold 30,000 shares
@ $32.11, valued at
$963.3k
Sold 1,787 shares
@ $32.1658, valued at
$57.5k
Exercised 30,000 options to buy
@ $6.48, valued at
$194.4k
Exercised 1,787 options to buy
@ $6.48, valued at
$11.6k
|
|
| 03/07/2019 |
4
| Soteropoulos Paula (CEO) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Sold 18,386 shares
@ $32.1362, valued at
$590.9k
Exercised 18,386 options to buy
@ $6.48, valued at
$119.1k
|
|
| 01/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2019 |
4
| Soteropoulos Paula (CEO) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Granted 296,000 options to buy
@ $30.73, valued at
$9.1M
|
|
| 01/31/2018 |
4
| Soteropoulos Paula (Director) has filed a Form 4 on uniQure N.V.|
Txns:
| Sold 2,878 shares
@ $18.53, valued at
$53.3k
|
|
| 01/30/2018 |
4
| Soteropoulos Paula (Director) has filed a Form 4 on uniQure N.V.|
Txns:
| Granted 4,792 shares
@ $0
Granted 6,390 options to buy
@ $19.39, valued at
$123.9k
|
|
| 01/04/2018 |
4
| Soteropoulos Paula (President & CEO) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Granted 275,000 options to buy
@ $17.38, valued at
$4.8M
|
|
| 07/13/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/31/2017 |
4
| Soteropoulos Paula (Director) has filed a Form 4 on uniQure N.V.|
Txns:
| Granted 11,000 options to buy
@ $5.37, valued at
$59.1k
Granted 11,000 restricted stock units
@ $0 |
|
| 01/03/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|